Intervention 1: Intervention group: Administration of 3 mg tablet of melatonin provided by Razak pharmaceutical Company, 6 mg daily (twice a day orally) for 4 weeks and then baseline and 4-weeks follo

2 trials

Sponsors

Esfahan University of Medical Sciences

Conditions

Breast cancer. Malignant neoplasm of breastProstate cancer. Malignant neoplasm of prostate

Phase 3

Melatonin in the management of breast cancer patients

Active, not recruitingIRCT20180722040556N3

Esfahan University of Medical SciencesBreast cancer. Malignant neoplasm of breast

Start: 2020-05-19Target: 60Updated: 2020-05-18

Evaluation of the effect of melatonin in the treatment of problems caused by androgen deprivation therapy in prostate cancer patients

RecruitingIRCT20180722040556N5

Esfahan University of Medical SciencesProstate cancer. Malignant neoplasm of prostate

Start: 2020-05-18Target: 66Updated: 2020-09-07